Ghent University Academic Bibliography

Show Sort by

Your filters: cql: parent exact "NEURO-ONCOLOGY"

Add to list
- Conference Paper
- C3
Cancer registration and adherence to the WHO 2016 classification of pathology reports for astrocytic tumors in Belgium from 2017 to 2019

D J Vanhauwaert, Harry Pinson (UGent) , F Dedeurwaerdere, A Leloup, K Vanschoenbeek, C De Gendt, H De Schutter, S De Vleeschouwer and Tom Boterberg (UGent)

(2022) NEURO-ONCOLOGY. In Neuro-oncology 24(supplement 2). p.ii63-ii63
Add to list
- Conference Paper
- C3
Quality indicators in neuro-oncology : modified Delphi process for the development of a quality indicator set for assessment of glioma care

D J Vanhauwaert, Harry Pinson (UGent) , H De Schutter, E Van Eycken, S De Vleeschouwer and Tom Boterberg (UGent)

(2021) NEURO-ONCOLOGY. In Neuro-oncology 23(Supplement 2). p.42-42
Add to list
- Conference Paper
- C3
Lack of correlation between incidental ipsilateral subventricular zone radiation dose and overall survival in glioblastoma patients

Giorgio Hallaert (UGent) , Harry Pinson (UGent) , Dimitri Vanhauwaert, Lorenzo Staelens, Caroline Vandenbroecke, Dirk Van Roost (UGent) , Jean-Pierre Kalala Okito (UGent) and Tom Boterberg (UGent)

(2019) NEURO-ONCOLOGY. In Neuro-Oncology 21(Suppl 3). p.95-96
Add to list
- Conference Paper
- C3
Standard error of measurement (SEM) and intraclass coefficient (ICC) in volumetric assessment of postoperative residual tumor volume in glioblastoma

Giorgio Hallaert (UGent) , Harry Pinson (UGent) , Dirk Van Roost (UGent) , Jean-Pierre Kalala Okito (UGent) , Vicky Vandriessche (UGent) and Tom Boterberg (UGent)

(2019) NEURO-ONCOLOGY. 21(suppl. 3). p.iii94-iii94
Add to list
Temporal muscle thickness is an independent prognostic marker in patients with progressive glioblastoma : translational imaging analysis of the EORTC 26101 trial

Julia Furtner, Els Genbrugge, Thierry Gorlia, Martin Bendszus, Martha Nowosielski, Vassilis Golfinopoulos, Michael Weller, Martin J. Van den Bent, Wolfgang Wick and Matthias Preusser

(2019) NEURO-ONCOLOGY. 21(12). p.1587-1594
Add to list
- Conference Paper
- C3
- open access
Cost-effectiveness of [18F]FET for therapy assessment of temozolomide for patients with glioblastoma in a Belgian healthcare setting

Tristan Baguet, Jeroen Verhoeven (UGent) , Filip De Vos (UGent) and Ingeborg Goethals (UGent)

(2018) NEURO-ONCOLOGY. 20(suppl. 3).
Add to list
Radiomics and machine learning on [18F]FET PET and T1ce MRI discriminate between low-grade and high-grade glioma

Stijn Bonte, Sam Donche, Michaël Henrotte (UGent) , Roel Van Holen (UGent) and Ingeborg Goethals (UGent)

(2018) NEURO-ONCOLOGY. 20(suppl. 3). p.iii226-iii226
Add to list
- Conference Paper
- C3
Absence of correlation between necrosis volume and overall survival in glioblastoma

Giorgio Hallaert (UGent) , Harry Pinson (UGent) , Caroline Vandenbroecke, Dimitri Vanhauwaert, Dirk Van Roost (UGent) and Tom Boterberg (UGent)

(2018) NEURO-ONCOLOGY. 20(suppl. 3). p.iii229-iii229
Add to list
The role of PET- and MRI-derived [18F]FET PET parameters in the discrimination of low- and high-grade gliomas

Sam Donche, Michaël Henrotte (UGent) , Stijn Bonte, Jeroen Verhoeven (UGent) , Caroline Van den Broecke (UGent) , Marjan Acou (UGent) and Ingeborg Goethals (UGent)

(2018) NEURO-ONCOLOGY. 20(suppl. 3). p.iii241-iii241
Add to list
- Conference Paper
- C3
- open access
In vitro and in vivo evaluation of the LAT1 PET tracer 2-[18F]FELP in comparison to [18F]FET and [18F]FDG

Jeroen Verhoeven (UGent) , Julie Bolcaen (UGent) , Ken Kersemans (UGent) , Valerie De Meulenaere (UGent) , Benedicte Descamps (UGent) , Jean-Pierre Kalala Okito (UGent) , Caroline Van den Broecke (UGent) , Karel Deblaere (UGent) , Christian Vanhove (UGent) , Ingeborg Goethals (UGent) , et al.

(2017) NEURO-ONCOLOGY. 19(suppl. 3). p.46-46

Academic Bibliography

Cancer registration and adherence to the WHO 2016 classification of pathology reports for astrocytic tumors in Belgium from 2017 to 2019

Quality indicators in neuro-oncology : modified Delphi process for the development of a quality indicator set for assessment of glioma care

Lack of correlation between incidental ipsilateral subventricular zone radiation dose and overall survival in glioblastoma patients

Standard error of measurement (SEM) and intraclass coefficient (ICC) in volumetric assessment of postoperative residual tumor volume in glioblastoma

Temporal muscle thickness is an independent prognostic marker in patients with progressive glioblastoma : translational imaging analysis of the EORTC 26101 trial

Cost-effectiveness of [18F]FET for therapy assessment of temozolomide for patients with glioblastoma in a Belgian healthcare setting

Radiomics and machine learning on [18F]FET PET and T1ce MRI discriminate between low-grade and high-grade glioma

Absence of correlation between necrosis volume and overall survival in glioblastoma

The role of PET- and MRI-derived [18F]FET PET parameters in the discrimination of low- and high-grade gliomas

In vitro and in vivo evaluation of the LAT1 PET tracer 2-[18F]FELP in comparison to [18F]FET and [18F]FDG

Contents

Support

Contact